Your browser doesn't support javascript.
Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic.
Guihaire, Julien; Owyang, Clark G; Madhok, Jai; Laverdure, Florent; Gaillard, Maïra; Girault, Antoine; Lebreton, Guillaume; Mercier, Olaf.
  • Guihaire J; From the Department of Cardiac Surgery, Pulmonary Hypertension National Referral Center, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, Paris, France.
  • Owyang CG; Paris-Saclay University School of Medicine, Le Kremlin-Bicêtre, France.
  • Madhok J; INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France.
  • Laverdure F; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.
  • Gaillard M; Department of Anesthesiology, Pain, and Perioperative Medicine, Division of Critical Care Medicine, Stanford University School of Medicine, California.
  • Girault A; Department of Anesthesiology and Intensive Care, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, Paris, France.
  • Lebreton G; From the Department of Cardiac Surgery, Pulmonary Hypertension National Referral Center, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, Paris, France.
  • Mercier O; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, Paris, France.
ASAIO J ; 66(10): 1069-1072, 2020.
Article in English | MEDLINE | ID: covidwho-670484
ABSTRACT
Extracorporeal membrane oxygenation (ECMO) is recognized as organ support for potentially reversible acute respiratory distress syndrome (ARDS). However, limited resource during the outbreak and the coagulopathy associated with coronavirus disease 2019 (COVID-19) make the utilization of venovenous (VV) ECMO highly challenging. We herein report specific considerations for cannulation configurations and ECMO management during the pandemic. High blood flow and anticoagulation at higher levels than usual practice for VV ECMO may be required because of thrombotic hematologic profile of COVID-19. Among our first 24 cases (48.8 ± 8.9 years), 17 patients were weaned from ECMO after a mean duration of 19.0 ± 10.1 days and 16 of them have been discharged from ICU.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Extracorporeal Membrane Oxygenation / Coronavirus Infections Type of study: Observational study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: ASAIO J Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: MAT.0000000000001251

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Extracorporeal Membrane Oxygenation / Coronavirus Infections Type of study: Observational study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Language: English Journal: ASAIO J Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: MAT.0000000000001251